These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17706139)

  • 41. [Promotive effects of epoxyeicosatrienoic acids (EETs) on proliferation of tumor cells].
    Shen GF; Jiang JG; Fu XN; Wang DW
    Ai Zheng; 2008 Nov; 27(11):1130-6. PubMed ID: 19000441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of the PI3K/AKT signaling pathway sensitizes diffuse large B-cell lymphoma cells to treatment with proteasome inhibitors via suppression of BAG3.
    Yuan T; Zhang F; Zhou X; Li Y; Zhang Y; Xu Y; Wang X
    Oncol Lett; 2019 Apr; 17(4):3719-3726. PubMed ID: 30881494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PMA/IONO affects diffuse large B-cell lymphoma cell growth through upregulation of A20 expression.
    Yang W; Li Y; Li P; Wang L
    Oncol Rep; 2016 Aug; 36(2):1069-75. PubMed ID: 27349720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomas.
    Faber AC; Dufort FJ; Blair D; Wagner D; Roberts MF; Chiles TC
    Biochem Pharmacol; 2006 Nov; 72(10):1246-56. PubMed ID: 16979140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphoinositide 3-kinase inhibitor LY294002 but not serum withdrawal suppresses proliferation of murine embryonic stem cells.
    Lianguzova MS; Chuykin IA; Nordheim A; Pospelov VA
    Cell Biol Int; 2007 Apr; 31(4):330-7. PubMed ID: 17321171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fc receptor-like 1 (FCRL1) is a novel biomarker for prognosis and a possible therapeutic target in diffuse large B-cell lymphoma.
    Yousefi Z; Sharifzadeh S; Zare F; Eskandari N
    Mol Biol Rep; 2023 Feb; 50(2):1133-1145. PubMed ID: 36409389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphoma.
    Bongero D; Paoluzzi L; Marchi E; Zullo KM; Neisa R; Mao Y; Escandon R; Wood K; O'Connor OA
    Leuk Lymphoma; 2015; 56(10):2945-52. PubMed ID: 25860245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Y-box-binding protein-1 (YB-1) promotes cell proliferation, adhesion and drug resistance in diffuse large B-cell lymphoma.
    Miao X; Wu Y; Wang Y; Zhu X; Yin H; He Y; Li C; Liu Y; Lu X; Chen Y; Shen R; Xu X; He S
    Exp Cell Res; 2016 Aug; 346(2):157-66. PubMed ID: 27397581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antitumor effects of rafoxanide in diffuse large B cell lymphoma via the PTEN/PI3K/Akt and JNK/c-Jun pathways.
    He W; Xu Z; Song D; Zhang H; Li B; Gao L; Zhang Y; Feng Q; Yu D; Hu L; Chen G; Tao Y; Wu X; Shi J; Zhu W
    Life Sci; 2020 Feb; 243():117249. PubMed ID: 31926247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Co-treatment of LY294002 or MK-2206 with AZD5363 Attenuates AZD5363-induced Increase in the Level of Phosphorylated AKT.
    Choi AR; Kim JH; Woo YH; Cheon JH; Kim HS; Yoon S
    Anticancer Res; 2016 Nov; 36(11):5849-5858. PubMed ID: 27793908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma.
    Zhang T; Guan XW; Gribben JG; Liu FT; Jia L
    Cell Death Dis; 2019 Apr; 10(5):330. PubMed ID: 30988279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma.
    Cui W; Cai Y; Wang W; Liu Z; Wei P; Bi R; Chen W; Sun M; Zhou X
    J Transl Med; 2014 Jan; 12():10. PubMed ID: 24418330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Soluble CXCL16 promotes TNF-α-induced apoptosis in DLBCL via the AMAD10-NF-κB regulatory feedback loop.
    Yang H; Qiu B; Chen S; Xun Y; Pan Y; Chen M; Li WX; Liao W; El-Ashram S; Yang A; Liu F
    Cell Biol Int; 2019 Aug; 43(8):863-874. PubMed ID: 31033093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-DLBCL efficacy of DCZ0825 in vitro and in vivo: involvement of the PI3K‒AKT‒mTOR/JNK pathway.
    Hu K; Li B; Ma R; Yi H; Xu Z; Peng Y; Yu D; Wu H; Cheng T; Lu Y; Zhang Y; Wei R; Yang G; Wu X; Zhu W; Shi J
    Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):575-583. PubMed ID: 33821934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PAQR3 facilitates the ferroptosis of diffuse large B-cell lymphoma via the regulation of LDLR-mediated PI3K/AKT pathway.
    Song X; Zhang W; Yu N; Zhong X
    Hematol Oncol; 2024 Jan; 42(1):e3219. PubMed ID: 37690092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CAPG facilitates diffuse large B-cell lymphoma cell progression through PI3K/AKT signaling pathway.
    Wang G; Liu H; An L; Hou S; Zhang Q
    Hum Immunol; 2022 Dec; 83(12):832-842. PubMed ID: 36244872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Inhibitory Effect of LY294002 on Proliferation of Multiple Myeloma Cells and Its Mechanism].
    Wang YQ; Lin Y; Zhao JD; Yang YT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1092-1096. PubMed ID: 28823274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel benzoxazinone derivative YLT-LL-11 inhibits diffuse large B-cell lymphoma growth via inducing cell cycle arrest and apoptosis.
    Peng C; Sun C; Wang N; He Y; Xu J; Deng Y; Gao L; Zhong J; Xiong X; Liu L
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31527063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Arachidonoyl-phosphatidylcholine oscillates during the cell cycle and counteracts proliferation by suppressing Akt membrane binding.
    Koeberle A; Shindou H; Koeberle SC; Laufer SA; Shimizu T; Werz O
    Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2546-51. PubMed ID: 23359699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of CD300A inhibits the growth of diffuse large B-cell lymphoma.
    Jiang L; Xu Y; Zeng X; Fang J; Morse HC; Zhou JX
    Oncotarget; 2015 Oct; 6(31):31191-202. PubMed ID: 26435477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.